Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery

Biomaterials

Volumn 34, Issue 4, 2013, Pages 1289-1301

  Biswas, Swati ^a   Deshpande, Pranali P ^a   Navarro, Gemma ^a   Dodwadkar, Namita S ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Co delivery; Dendrimer; PEG PE; SiRNA

Indexed keywords

CELL PENETRATION; CELLULAR INTERACTION; CELLULAR UPTAKE; CO-DELIVERY; DOWN-REGULATION; DOXORUBICIN; INTRACELLULAR DELIVERY; LOADING EFFICIENCY; MIXED MICELLAR SYSTEM; MOLAR RATIO; NANOCARRIERS; PAMAM DENDRIMER; PEG-PE; POLYAMIDOAMINE DENDRIMERS; POLYPLEXES; RNA INTERFERENCE; SELF-ASSEMBLED; SERUM STABILITY; SIRNA; SIRNA DELIVERY; SMALL INTERFERING RNA (SIRNA); TARGET PROTEINS; TRIBLOCKS;

CONDENSATION; DENDRIMERS; ENZYME INHIBITION; MICELLIZATION; POLYETHYLENE GLYCOLS; PROTEINS; RNA;

MICELLES;

DOXORUBICIN; LIPID; NANOCARRIER; POLYAMIDOAMINE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; HYDROPHOBICITY; MICELLIZATION; NONHUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DENDRIMERS; DOXORUBICIN; DRUG COMBINATIONS; HUMANS; LUNG NEOPLASMS; NANOCAPSULES; PHOSPHATIDYLETHANOLAMINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TREATMENT OUTCOME;

EID: 84870368308     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.10.024     Document Type: Article

References (42)

1. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411(6836):494-498.
2. Hannon G.J. RNA interference. Nature 2002, 418(6894):244-251.
3. Hannon G.J., Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 2004, 431(7006):371-378.
4. Whitehead K.A., Langer R., Anderson D.G. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009, 8(2):129-138.
5. Wang J., Lu Z., Wientjes M.G., Au J.L. Delivery of siRNA therapeutics: barriers and carriers. AAPS J 2010, 12(4):492-503.
6. Alexis F., Pridgen E., Molnar L.K., Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008, 5(4):505-515.
7. Gao K., Huang L. Nonviral methods for siRNA delivery. Mol Pharm 2009, 6(3):651-658.
8. Cheng C.J., Saltzman W.M. Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. Biomaterials 2011, 32(26):6194-6203.
9. Lungwitz U., Breunig M., Blunk T., Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 2005, 60(2):247-266.
10. Zintchenko A., Philipp A., Dehshahri A., Wagner E. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem 2008, 19(7):1448-1455.
11. Zhang S., Zhao B., Jiang H., Wang B., Ma B. Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 2007, 123(1):1-10.
12. Wu Z.W., Chien C.T., Liu C.Y., Yan J.Y., Lin S.Y. Recent progress in copolymer-mediated siRNA delivery. J Drug Target 2012, 20(7):551-560.
13. Hunter A.C. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev 2006, 58(14):1523-1531.
14. Taratula O., Garbuzenko O.B., Kirkpatrick P., Pandya I., Savla R., Pozharov V.P., et al. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J Control Release 2009, 140(3):284-293.
15. Liu J., Zhou J., Luo Y. SiRNA delivery systems based on neutral cross-linked dendrimers. Bioconjug Chem 2012, 23(2):174-183.
16. Waite C.L., Roth C.M. PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma. Bioconjug Chem 2009, 20(10):1908-1916.
17. Hayashi Y., Mori Y., Yamashita S., Motoyama K., Higashi T., Jono H., et al. Potential use of lactosylated dendrimer (G3)/alpha-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy. Mol Pharm 2012, 9(6):1645-1653.
18. Tang Y., Li Y.B., Wang B., Lin R.Y., van Dongen M., Zurcher D.M., et al. Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers. Mol Pharm 2012, 9(6):1812-1821.
19. Riordan J.R., Deuchars K., Kartner N., Alon N., Trent J., Ling V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 1985, 316(6031):817-819.
20. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full-length cDNA for the human " MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987, 84(9):3004-3008.
21. Patil Y.B., Swaminathan S.K., Sadhukha T., Ma L., Panyam J. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials 2010, 31(2):358-365.
22. Wang Y., Gao S., Ye W.H., Yoon H.S., Yang Y.Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 2006, 5(10):791-796.
23. Chen Y., Bathula S.R., Li J., Huang L. Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer. J Biol Chem 2010, 285(29):22639-22650.
24. Chen A.M., Zhang M., Wei D., Stueber D., Taratula O., Minko T., et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 2009, 5(23):2673-2677.
25. Sun T.M., Du J.Z., Yao Y.D., Mao C.Q., Dou S., Huang S.Y., et al. Simultaneous delivery of siRNA and paclitaxel via a " two-in-one" micelleplex promotes synergistic tumor suppression. ACS Nano 2011, 5(2):1483-1494.
26. Xiong X.B., Lavasanifar A. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano 2011, 5(6):5202-5213.
27. Alshamsan A., Haddadi A., Incani V., Samuel J., Lavasanifar A., Uludag H. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine. Mol Pharm 2009, 6(1):121-133.
28. Liu C., Zhao G., Liu J., Ma N., Chivukula P., Perelman L., et al. Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel. J Control Release 2009, 140(3):277-283.
29. Gusachenko Simonova O., Kravchuk Y., Konevets D., Silnikov V., Vlassov V.V., Zenkova M.A. Transfection efficiency of 25-kDa PEI-cholesterol conjugates with different levels of modification. J Biomater Sci Polym Ed 2009, 20(7-8):1091-1110.
30. Han S., Mahato R.I., Kim S.W. Water-soluble lipopolymer for gene delivery. Bioconjug Chem 2001, 12(3):337-345.
31. Ko Y.T., Kale A., Hartner W.C., Papahadjopoulos-Sternberg B., Torchilin V.P. Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery. J Control Release 2009, 133(2):132-138.
32. Navarro G., Sawant R.R., Biswas S., Essex S., Tros de Ilarduya C., Torchilin V.P. P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells. Nanomedicine (Lond) 2012, 7(1):65-78.
33. Biswas S., Dodwadkar N.S., Sawant R.R., Torchilin V.P. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization. Bioconjug Chem 2011, 22(10):2005-2013.
34. Biswas S., Dodwadkar N.S., Sawant R.R., Koshkaryev A., Torchilin V.P. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting. J Drug Target 2011, 19(7):552-561.
35. Biswas S., Dodwadkar N.S., Deshpande P.P., Torchilin V.P. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release 2012, 159(3):393-402.
36. Musacchio T., Vaze O., D'Souza G., Torchilin V.P. Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles. Bioconjug Chem 2010, 21(8):1530-1536.
37. Torchilin V.P., Levchenko T.S., Lukyanov A.N., Khaw B.A., Klibanov A.L., Rammohan R., et al. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim Biophys Acta 2001, 1511(2):397-411.
38. Musacchio T., Laquintana V., Latrofa A., Trapani G., Torchilin V.P. PEG-PE micelles loaded with paclitaxel and surface-modified by a PBR-ligand: synergistic anticancer effect. Mol Pharm 2009, 6(2):468-479.
39. Jones M., Leroux J. Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999, 48(2):101-111.
40. Patil M.L., Zhang M., Minko T. Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing. ACS Nano 2011, 5(3):1877-1887.
41. Biswas S., Dodwadkar N.S., Piroyan A., Torchilin V.P. Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biomaterials 2012, 33(18):4773-4782.
42. Torchilin V.P. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006, 58(14):1532-1555.